|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2001-2-7
|
|
pubmed:abstractText |
Non-small cell lung cancer (NSCLC) is resistant to chemotherapy and prognosis of advanced NSCLC patients is considered to be dependent on various prognostic factors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0368-2811
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
534-41
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11210162-Adult,
pubmed-meshheading:11210162-Aged,
pubmed-meshheading:11210162-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11210162-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:11210162-Female,
pubmed-meshheading:11210162-Humans,
pubmed-meshheading:11210162-Lung Neoplasms,
pubmed-meshheading:11210162-Male,
pubmed-meshheading:11210162-Middle Aged,
pubmed-meshheading:11210162-Multivariate Analysis,
pubmed-meshheading:11210162-Phosphopyruvate Hydratase,
pubmed-meshheading:11210162-Prognosis,
pubmed-meshheading:11210162-Retrospective Studies,
pubmed-meshheading:11210162-Survival Analysis,
pubmed-meshheading:11210162-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Prognostic factors in advanced non-small cell lung cancer: elevated serum levels of neuron specific enolase indicate poor prognosis.
|
|
pubmed:affiliation |
Department of Internal Medicine II, Okayama University Medical School, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
